Previous close | 9.50 |
Open | 9.30 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 65.00 |
Expiry date | 2025-02-21 |
Day's range | 9.30 - 9.50 |
Contract range | N/A |
Volume | |
Open interest | 134 |
DexCom (DXCM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IRVINE, Calif., October 17, 2024--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended September 30, 2024 after the market closes on Thursday, October 24, 2024, and will host a conference call at 5:30 p.m. ET that day to discuss those results.
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund’s Investor Class fund ARTMX returned 2.35%, Advisor Class fund APDMX posted a return of 2.38%, and Institutional Class fund APHMX returned 2.40%, compared […]